Washington University center to help patients and survivors access cancer genomic sequencing
Washington University Participant Engagement and Cancer Genomic Sequencing Center (WU-PE-CGS)
This center develops ways to reach and involve cancer patients and survivors—especially those with rare or high-risk cancers—in genomic sequencing and follow-up care.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Washington University NIH-funded |
| Lab location | 1 site (Saint Louis, United States) |
| Project ID | NIH-11191577 on NIH RePORTER |
What this research studies
This center brings together researchers, patients, and community partners to create and test practical ways to engage people in genomic sequencing studies. The work focuses on patients and post-treatment survivors with cancers that have poor outcomes, including cholangiocarcinoma, multiple myeloma, and colorectal cancer, with special attention to low-resourced communities. The center will run ongoing projects that collect genomic data, improve consent and communication, and track active follow-up to see what outreach methods work best. Findings and tools will be shared to help hospitals and clinics better recruit and support patients who might benefit from genomic information.
Who could benefit from this research
Good fit: Patients and post-treatment survivors with cholangiocarcinoma, multiple myeloma, colorectal cancer, or other cancers who are willing to participate in genomic sequencing and engagement activities, especially from low-resourced communities.
Not a fit: People without a cancer diagnosis, those not interested in genomic testing, or patients whose treatment is unrelated to genomic findings may not directly benefit from this work.
Why it matters
Potential benefit: Could make it easier for underserved cancer patients and survivors to get genomic testing, understandable results, and improved follow-up that may inform care.
How similar studies have performed: Related engagement and genomic programs have improved enrollment and return of results, but applying these methods specifically to rare cancers and underserved survivors at this scale is relatively new.
Where this research is happening
Saint Louis, United States
- Washington University — Saint Louis, United States (Active)
Researchers
- Principal investigator: Colditz, Graham a. — Washington University
- Study coordinator: Colditz, Graham a.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.